Chen et al., 2009 - Google Patents
SERIAL HBV-DNA LEVELS OVER 10 YEARS AFTER SPONTANEOUS HBEAG SEROCONVERSION IN PATIENTS WITH SUSTAINED REMISSION: 1499Chen et al., 2009
- Document ID
- 9642970179510505856
- Author
- Chen Y
- Liaw Y
- Publication year
- Publication venue
- Hepatology
External Links
Snippet
Yi-Cheng Chen, Yun-Fan Liaw; Liver Research Unit, Chang Gung Memorial Hospital and University, Taoyuan, Taiwan Background and Objectives: There has been controversy on the hepatitis B virus (HBV) DNA level in inactive chronic HBV infection. Serial HBV-DNA in …
- 230000002269 spontaneous effect 0 title abstract description 6
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jiang et al. | Th1 and Th2 immune response in chronic hepatitis B patients during a long‐term treatment with adefovir dipivoxil | |
| Zoulim | Antiviral therapy of chronic hepatitis B | |
| Chen et al. | Therapeutic effect of autologous dendritic cell vaccine on patients with chronic hepatitis B: a clinical study | |
| Zacharakis et al. | The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg (−) hepatitis B infection: association with liver disease progression. A prospective cohort study | |
| Yao et al. | Therapeutic effect of hepatitis B surface antigen–antibody complex is associated with cytolytic and non-cytolytic immune responses in hepatitis B patients | |
| Cheng et al. | Association of intrahepatic cccDNA reduction with the improvement of liver histology in chronic hepatitis B patients receiving oral antiviral agents | |
| Abu-Amara et al. | Does antiviral therapy for chronic hepatitis B reduce the risk of hepatocellular carcinoma? | |
| Li et al. | Association of cytokines with alanine aminotransferase, hepatitis B virus surface antigen and hepatitis B envelope antigen levels in chronic hepatitis B | |
| Leung | Clinical experience with lamivudine | |
| Yeh et al. | Withdrawal of lamivudine in HBeAg-positive chronic hepatitis B patients after achieving effective maintained virological suppression | |
| Li et al. | Beneficial therapeutic effect of Chinese herbal Bushen formula on CHB patients with mildly elevated alanine aminotransferase by down-regulating CD4+ CD25+ T cells | |
| Li et al. | Plasmacytoid dendritic cell function and cytokine network profiles in patients with acute or chronic hepatitis B virus infection | |
| Chen et al. | SERIAL HBV-DNA LEVELS OVER 10 YEARS AFTER SPONTANEOUS HBEAG SEROCONVERSION IN PATIENTS WITH SUSTAINED REMISSION: 1499 | |
| Lucifora et al. | IRF-3 IS INVOLVED IN THE RESTRICTION OF BACULOVIRUS-TRIGGERED HBV REPLICATION IN HEPARG CELLS: 1500 | |
| Cao et al. | Functional molecular expression of nature killer cells correlated to HBsAg clearance in HBeAg-positive chronic hepatitis B patients during PEG-IFN α-2a therapy | |
| Gujar et al. | Aberrant lymphocyte activation precedes delayed virus-specific T-cell response after both primary infection and secondary exposure to hepadnavirus in the woodchuck model of hepatitis B virus infection | |
| Amarapurkar et al. | Increased prevalence of type II diabetes mellitus in hepatitis C virus infection in western India | |
| Iser et al. | NO INCREASE IN INTRAHEPATIC MONONUCLEAR CELL OR STELLATE CELL ACTIVATION IN HIV-HBV COINFECTED INDIVIDUALS WITH ADVANCED HIV AND MILD LIVER DISEASE: 1498 | |
| Sonneveld et al. | 71 POLYMORPHISMS AT RS12979860 AND RS12980275 NEAR PREDICT SEROLOGICAL RESPONSE TO (PEG-) INTERFERON IN HBEAG-POSITIVE CHRONIC HEPATITIS B | |
| Pawlowska et al. | Virological response to treatment with peginterferon alfa-2a in adolescents with chronic hepatitis B. | |
| Zhang et al. | Pathogenesis of hepatitis B virus infection | |
| Seto et al. | Interim analysis of hepatitis B reactivation in patients with prior HBV exposure undergoing rituximab-containing chemotherapy: a prospective study: 34 | |
| Lazarevic et al. | Biological features of hepatitis B virus strains associated with fulminant hepatitis | |
| Isaguliants | Functionality of the immune system in patients with chronic hepatitis C: trial by superinfections and vaccinations | |
| Al Mahtab et al. | Liver Histopathological Features of HBeAg-Negative Chronic Hepatitis B in Young Bangladeshis |